Back to search

Article

The Affordable Intervention Cost Ceiling: a burden-derived economic framework for cardiovascular–kidney–metabolic prevention in China, Japan, and South Korea

2026-05-08

Abstract excerpt

<title>Abstract</title> <p>Background. How much can a country reasonably spend per person each year on cardiovascular–kidney–metabolic (CKM) prevention before a full health technology assessment is warranted? Conventional tools answer this only obliquely. We propose the Affordable Intervention Cost Ceiling (AICC), a stage-stratified upper bound derived from country-specific disease burden, and apply it to China,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1f0f8e45-2380-5c22-a3af-f6b12347fa3a
DOI
10.21203/rs.3.rs-9562745/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The Affordable Intervention Cost Ceiling: a burden-derived economic framework for cardiovascular–kidney–metabolic prevention in China, Japan, and South KoreaDOI 10.21203/rs.3.rs-9562745/v1
The Economic Impact of National Essential Public Health Service Package for Hypertension and Type-2 Diabetes: A Retrospective Province-wide Study in ChinaSemantic proximity
Inference of Disease Burden for Chronic Kidney Disease Screening Intervention Based on a Micro-Simulation ModelSemantic proximity
Burden of Chronic Kidney Disease in India: Past, Present, and Future Projections to 2040 from the Global Burden of Disease 2021 StudySemantic proximity
Cardiorenal outcomes of tirzepatide versus semaglutide in adults with type 2 diabetes and chronic kidney disease: a target trial emulation in the TriNetX Global Collaborative NetworkSemantic proximity
Estimates of non-communicable disease expenditure by disease phase, sex, and age group for all OECD countriesSemantic proximity
Determining Cost-Saving Risk Thresholds for Statin UseSemantic proximity
How Has the Current Curative Expenditure of Noncommunicable Diseases Changed? Evidence From China in 2017-2019Semantic proximity
Research on Current Curative Expenditure and Influencing Factors Among Cardiovascular and Cerebrovascular Diseases Based on “System of Health Accounts 2011”Semantic proximity
Metoprolol Population Pharmacokinetics in Older Chinese Patients With CKM Syndrome: Joint Effects of rs1065852 and CKM2S2-BAG Score on Clearance.Semantic proximity
ESTIMATING THE HEALTH AND ECONOMIC EFFECTS OF THE VOLUNTARY SODIUM REDUCTION TARGETS IN BRAZIL: MICROSIMULATION ANALYSISSemantic proximity
Cost-Utility Analysis of Pitavastatin in Dyslipidemia: Vietnam CaseSemantic proximity
Use of over-the-counter-like drugs among adults with indicated chronic diseases: A nationwide descriptive study in JapanSemantic proximity
Select a neighboring publication to make it the new centre.